Table 3.
Adverse events |
Nab-paclitaxel |
CrEL paclitaxel |
---|---|---|
% of pts | % of pts | |
Neutropenia | 23 | 59 |
Leukopenia | 10 | 31 |
Nausea | 20 | 38 |
Hyperglycemya | 0 | 19 |
Flushing | 0 | 16 |
Adverse events |
Nab-paclitaxel |
CrEL paclitaxel |
---|---|---|
% of pts | % of pts | |
Neutropenia | 23 | 59 |
Leukopenia | 10 | 31 |
Nausea | 20 | 38 |
Hyperglycemya | 0 | 19 |
Flushing | 0 | 16 |